论文部分内容阅读
目的:研究黄芪注射液对急性脑梗塞患者红细胞变形指数(IF)的影响及其与近期疗效的关系。方法:对采用黄芪注射液加常规药物治疗的研究组和只使用常规药物治疗的对照组各32例急性脑梗塞患者治疗前后作IF、全血比粘度(NB)、血球压积(HCT)检测,并评估近期疗效。结果:治疗后组间对照显示研究组IF明显减少(P<0.05),提示红细胞变形能力(ED)增强;同时研究组近期疗效显著高于对照组(P<0.05)。结论:黄芪注射液有效改善ED的作用,可能是提高急性脑梗塞患者近期疗效的药物之一。
Objective: To study the effect of Astragalus injection on erythrocyte deformability index (IF) in patients with acute cerebral infarction and its relationship with short-term curative effect. Methods: The IF, whole blood specific viscosity (NB) and hematocrit (HCT) were measured before and after treatment in 32 cases of acute cerebral infarction patients treated with astragalus injection plus conventional drugs and those in the control group treated with conventional drugs only. , And assess the recent efficacy. Results: After treatment, the control group showed significantly decreased IF (P <0.05), which indicated that the erythrocyte deformability (ED) was enhanced. The efficacy of the study group was significantly higher than that of the control group (P <0.05). Conclusion: Astragalus injection can effectively improve the effect of ED and may be one of the drugs to improve the short-term curative effect of patients with acute cerebral infarction.